AKT1 and endocrine system disorder: KEGG pathway screening with p < 0.05 identified 30 signaling pathways, including lipid and atherosclerosis, PI3K-Akt signaling, atherosclerosis, diabetic complications, human cytomegalovirus infection, cellular senescence, and endocrine disorders.